EDGAR Filing Documents for 0001193125-16-478450

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001193125-16-478450

Filing Date

2016-02-25

Accepted

2016-02-25 16:39:30

Documents

Group Members

NOVARTIS AG

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	d119480dsc13g.htm	SC 13G	53491
2	EX-99.1	d119480dex991.htm	EX-99.1	9000
3	EX-99.2	d119480dex992.htm	EX-99.2	4509
4	EX-99.3	d119480dex993.htm	EX-99.3	4786
	Complete submission text file	0001193125-16-478450.txt		73422

Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000

Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210

Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139

Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096

PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89403 | Film No.: 161456475
SIC: 2834 Pharmaceutical Preparations